A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer



Status:Completed
Conditions:Cancer, Cancer, Gastrointestinal
Therapuetic Areas:Gastroenterology, Oncology
Healthy:No
Age Range:18 - Any
Updated:7/4/2018
Start Date:March 2010
End Date:August 2013

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this study is to evaluate the investigators ability to obtain reliable and
meaningful 11C-Choline PET-CT images of esophageal cancer.


Inclusion Criteria:

- Newly diagnosed or recurrent patients with locally advanced esophageal cancer with
either squamous or adenocarcinoma histology.

- Ability to tolerate PET imaging

- Prior malignancy is allowed, but the expectation of survival must be that beyond that
expected for patients with locally advanced esophageal cancer.

Exclusion Criteria:

- Pregnant or lactating females are not eligible for this pilot study.

- Patients having received chemotherapy in the 3 months prior to registration for any
reason

- Patients with metastatic disease requiring chemoradiation for palliation are not
allowed.
We found this trial at
1
site
Wake Forest University Health Sciences
1 Medical Center Blvd
Winston-Salem, North Carolina 27157
336-716-2011
Wake Forest University Health Sciences Welcome to Wake Forest Baptist Medical Center, a fully integrated...
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials